|
KPNA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.04060000195273E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.70599999996346E-06 |
| Normal-vs-Stage2 |
1.420080E-04 |
| Normal-vs-Stage3 |
4.03379999958098E-07 |
| Normal-vs-Stage4 |
2.9436999999799E-06 |
| Stage1-vs-Stage2 |
2.962600E-01 |
| Stage1-vs-Stage3 |
2.358600E-01 |
| Stage1-vs-Stage4 |
2.618000E-01 |
| Stage2-vs-Stage3 |
8.634200E-01 |
| Stage2-vs-Stage4 |
9.314200E-01 |
| Stage3-vs-Stage4 |
9.282400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.1026999998457E-08 |
| Normal-vs-AfricanAmerican |
1.150100E-04 |
| Normal-vs-Asian |
4.800800E-01 |
| Caucasian-vs-AfricanAmerican |
8.678200E-01 |
| Caucasian-vs-Asian |
2.216200E-01 |
| AfricanAmerican-vs-Asian |
2.409000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06770003949208E-09 |
| Normal-vs-Female |
1.180150E-03 |
| Male-vs-Female |
1.028030E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.358800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.68379999999835E-05 |
| Normal-vs-Age(61-80Yrs) |
5.74540000020107E-08 |
| Normal-vs-Age(81-100Yrs) |
2.36360000016589E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.715600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.807200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.976400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.141430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.816900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.706300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.868600E-01 |
| Normal-vs-Grade 2 |
1.178980E-04 |
| Normal-vs-Grade 3 |
9.07369956948401E-10 |
| Normal-vs-Grade 4 |
1.88260000000273E-06 |
| Grade 1-vs-Grade 2 |
2.316600E-01 |
| Grade 1-vs-Grade 3 |
2.391700E-02 |
| Grade 1-vs-Grade 4 |
6.318300E-02 |
| Grade 2-vs-Grade 3 |
2.060400E-02 |
| Grade 2-vs-Grade 4 |
1.462030E-01 |
| Grade 3-vs-Grade 4 |
8.945000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.358110E-04 |
| Normal-vs-ccB subtype |
4.44160000001581E-06 |
| ccA subtype-vs-ccB subtype |
2.959000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.18709999999511E-05 |
| Normal-vs-N1 |
2.419400E-01 |
| N0-vs-N1 |
5.458400E-01 |
|
|
